VA tests cheaper hearing aids for veterans with hearing loss

What it does

This bill directs the VA to run a two-year pilot program testing whether over-the-counter hearing aids (FDA-cleared devices) work as well as prescription hearing aids for veterans with mild-to-moderate hearing loss, and whether covering them would be cost-effective. Veterans enrolled in VA care can participate if an audiologist confirms they're medically appropriate candidates. The bill also orders the Government Accountability Office to study hearing aid coverage gaps for all Americans with mild-to-moderate hearing loss and recommend whether the VA should permanently cover OTC hearing aids.

Why we flagged it

The bill's core mechanism is a time-limited demonstration project to test and evaluate OTC hearing aid coverage for VA beneficiaries, with a secondary GAO study on broader hearing aid access. It is a straightforward public-health pilot, not a permanent entitlement or a market intervention.

What the text implies

• If the pilot succeeds, permanent OTC hearing aid coverage could significantly increase VA hearing aid expenditures, though the bill frames this as a cost-benefit question to be answered by the demonstration itself.
• The requirement that participants have access to mobile phones and data/Wi-Fi may exclude some rural or lower-income veterans, potentially limiting the diversity of the pilot population despite the bill's stated goal of serving diverse populations.
• The bill's focus on mild-to-moderate hearing loss may implicitly deprioritize veterans with severe hearing loss, who may continue to rely on prescription aids and may not benefit from this expansion.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Veterans with hearing loss gain access to a potentially lower-cost, clinically validated hearing aid option through the VA, and the pilot's findings will inform whether permanent coverage should be extended. The bill imposes no restrictions on veterans' existing rights or remedies, and the GAO study may benefit all Americans with hearing loss by identifying coverage gaps.

Who stands to gain

• OTC hearing aid manufacturers (if permanent coverage is adopted post-pilot)
• Veterans (reduced out-of-pocket hearing aid costs if coverage is extended)

Named in the bill

Department of Veterans Affairs, Secretary of Veterans Affairs, Food and Drug Administration (FDA), Comptroller General of the United States, House Committee on Veterans' Affairs, Senate Committee on Veterans' Affairs, Veterans Integrated Services Networks

Where it stands

2 cosponsors: 1 Democrats, 1 Republicans.

• May 21, 2026 — Introduced · Congress.gov: “Introduced in House”
• May 21, 2026 — Referred to House Committee on Veterans' Affairs · Congress.gov: “Referred to the House Committee on Veterans' Affairs”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

1 lobbying clients named this bill on 1 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $1,370,000 in lobbying spend. A filing names 24 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 0% of bills with at least one filing.

Keith Self, the sponsor, reported $183,631 in PAC receipts in the 2026 cycle.

• Consumer Technology Association — $1,370,000 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.